132 related articles for article (PubMed ID: 33235778)
1. Pure erythroid leukemia.
Chen JC; Lee WY; Schaefer JK; Bixby DL
Clin Case Rep; 2020 Nov; 8(11):2286-2288. PubMed ID: 33235778
[TBL] [Abstract][Full Text] [Related]
2. Flow Cytometry Analysis Versus E-Cadherin Immunohistochemistry for the Diagnosis of Pure Erythroid Leukemia: A Case Report.
AlSwayyed A; Salamah B; Al-Moshary M; Hussein Karrar KAE; Khan A
Cureus; 2020 Jul; 12(7):e9055. PubMed ID: 32782874
[TBL] [Abstract][Full Text] [Related]
3. De Novo Pure Erythroid Leukemia With Rapid Progression and Multiple Lytic Bone Lesions: A Case Report.
Okazaki S
Cureus; 2023 Jul; 15(7):e41581. PubMed ID: 37559863
[TBL] [Abstract][Full Text] [Related]
4. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry-detected changes in megaloblastic anemia secondary to cobalamin deficiency.
Briones V; Figueroa F; Vidal C; Micolich V; Chandia M
Colomb Med (Cali); 2023; 54(2):e2005494. PubMed ID: 37649984
[TBL] [Abstract][Full Text] [Related]
6. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.
Reinig EF; Greipp PT; Chiu A; Howard MT; Reichard KK
Mod Pathol; 2018 May; 31(5):705-717. PubMed ID: 29327715
[TBL] [Abstract][Full Text] [Related]
7. Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy.
Tashakori M; Wang W; Kadia TM; Daver NG; Montalban-Bravo G; Loghavi S; Wang SA; Medeiros LJ; Ravandi F; Khoury JD
Leuk Res; 2022 Jul; 118():106860. PubMed ID: 35636055
[TBL] [Abstract][Full Text] [Related]
8. Complex karyotype with novel translocation in pure erythroid leukemia patient.
Aljabry M
Hematol Rep; 2015 Feb; 7(1):5674. PubMed ID: 25852849
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic profile of nucleated erythroid progenitors during maturation in regenerating bone marrow.
Fajtova M; Kovarikova A; Svec P; Kankuri E; Sedlak J
Leuk Lymphoma; 2013 Nov; 54(11):2523-30. PubMed ID: 23452116
[TBL] [Abstract][Full Text] [Related]
10. Congenital immature pure erythroid leukemia with E-cadherin expression.
Tamura A; Uemura S; Saito A; Okubo S; Nino N; Tahara T; Yokoi T; Kishimoto K; Ishida T; Hasegawa D; Kawasaki K; Yoshimoto S; Nakao H; Yoshida M; Kosaka Y
Int J Hematol; 2017 Nov; 106(5):711-717. PubMed ID: 28523571
[TBL] [Abstract][Full Text] [Related]
11. How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature.
Wong E; Ling V; Westerman D; Morgan S; Juneja S
J Clin Pathol; 2015 Apr; 68(4):301-5. PubMed ID: 25609576
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
13. Detection of BCR/ABL fusion product in normoblasts in a case of chronic myelogenous leukemia.
McFarlane R; Sun T
Am J Surg Pathol; 2004 Sep; 28(9):1240-4. PubMed ID: 15316326
[TBL] [Abstract][Full Text] [Related]
14. Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
Reichard KK; Tefferi A; Abdelmagid M; Orazi A; Alexandres C; Haack J; Greipp PT
Blood Cancer J; 2022 Nov; 12(11):147. PubMed ID: 36323674
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
[TBL] [Abstract][Full Text] [Related]
16. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
17. The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages.
Bühring HJ; Müller T; Herbst R; Cole S; Rappold I; Schuller W; Zhu X; Fritzsch U; Faul C; Armeanu S; Ullrich A; Klein G; Schmidt H
Leukemia; 1996 Jan; 10(1):106-16. PubMed ID: 8558914
[TBL] [Abstract][Full Text] [Related]
18. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY; Huang LJ; Liu Z; Garcia R; Li S; Galliani CA
Hum Pathol; 2011 May; 42(5):749-58. PubMed ID: 21237494
[TBL] [Abstract][Full Text] [Related]
19. Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.
Linu JA; Udupa MN; Madhumathi DS; Lakshmaiah KC; Babu KG; Lokanatha D; Babu MS; Lokesh KN; Rajeev LK; Rudresha AH
Ecancermedicalscience; 2017; 11():712. PubMed ID: 28144286
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD71 antibody immunohistochemistry in the diagnosis of acute myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat.
Suzuki S; Ogino N; Mitsui I; Ito H; Kariya T
J Vet Diagn Invest; 2021 Jan; 33(1):87-94. PubMed ID: 33225861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
